Brody Gene H, Yu Tianyi, Beach Steven R H
University of Georgia.
Dev Psychopathol. 2015 Feb;27(1):37-49. doi: 10.1017/S095457941400128X.
This study was designed to investigate a genetic moderation effect of dopamine receptor 4 gene (DRD4) alleles that have seven or more repeats (long alleles) on an intervention to deter drug use among rural African American adolescents in high-risk families. Adolescents (N = 291, M age = 17) were assigned randomly to the Adults in the Making (AIM) program or to a control condition and were followed for 27.5 months. Adolescents provided data on drug use and vulnerability cognitions three times after pretest. Pretest assessments of caregiver depressive symptoms, disruption in the home, and support toward the adolescent were used to construct a family risk index. Adolescents living in high-risk families who carried at least one DRD4 long allele and were assigned to the control condition evinced greater escalations in drug use than did (a) adolescents who lived in high-risk families, carried the DRD4 long allele, and were assigned to AIM, or (b) adolescents assigned to either condition who carried no DRD4 long alleles. AIM-induced reductions in vulnerability cognitions were responsible for the Family Risk × AIM × DRD4 status drug use prevention effects. These findings support differential susceptibility predictions and imply that prevention effects on genetically susceptible individuals may be underestimated.
本研究旨在调查多巴胺受体4基因(DRD4)七个或更多重复序列的等位基因(长等位基因)对农村非裔美国高危家庭青少年药物使用干预的遗传调节作用。青少年(N = 291,平均年龄 = 17岁)被随机分配到“成长中的成年人”(AIM)项目或对照组,并随访27.5个月。青少年在预测试后三次提供药物使用和易感性认知的数据。通过对照顾者抑郁症状、家庭破裂情况以及对青少年的支持进行预测试评估,构建了一个家庭风险指数。与(a)生活在高危家庭、携带DRD4长等位基因并被分配到AIM项目的青少年,或(b)被分配到任一条件但未携带DRD4长等位基因的青少年相比,生活在高危家庭且携带至少一个DRD4长等位基因并被分配到对照组的青少年药物使用情况有更大程度的上升。AIM项目引起的易感性认知降低是家庭风险×AIM×DRD4状态药物使用预防效果的原因。这些发现支持了差异易感性预测,并表明对基因易感个体的预防效果可能被低估。